Precision BioSciences Inc DTIL:NASDAQ

RT Quote | NASDAQ | USD
Last | 07/01/22 EDT
1.53quote price arrow down-0.07 (-4.38%)
Volume
5,469,110
52 week range
1.11 - 14.38
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.53
  • 52 Week High14.38
  • 52 Week High Date09/01/21
  • 52 Week Low1.11
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap149.56M
  • Shares Out97.75M
  • 10 Day Average Volume11.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change-79.32

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.53
  • 52 Week High14.38
  • 52 Week High Date09/01/21
  • 52 Week Low1.11
  • 52 Week Low Date06/16/22
  • Market Cap149.56M
  • Shares Out97.75M
  • 10 Day Average Volume11.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change-79.32

RATIOS/PROFITABILITY

  • EPS (TTM)-0.66
  • P/E (TTM)-2.33
  • Fwd P/E (NTM)-1.01
  • EBITDA (TTM)-39.233M
  • ROE (TTM)-62.39%
  • Revenue (TTM)102.50M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-39.10%
  • Debt To Equity (MRQ)3.56%

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Precision BioSciences Inc

There is no recent news for this security.

Profile

MORE
Precision BioSciences, Inc. is a clinical stage gene editing company. It is developing ex vivo allogeneic CAR T immunotherapies and in vivo therapies for genetic and infectious diseases with the application of its owned ARCUS genome editing platform. The Company's ARCUS platform is designed to deliver therapeutic-grade genome editing. Its ARCUS genome editing technology is for deoxyribonucleic acid (DNA) genome insertion, deletion and repair. Its ARCUS is based on a naturally...
Kevin Buehler
Lead Independent Chairman of the Board
Michael Amoroso
President, Chief Executive Officer, Director
Alex Kelly
Chief Financial Officer
Dario Scimeca
General Counsel, Secretary
Address
302 E Pettigrew St Ste A100
Durham, NC
27701-2393
United States

Top Peers

SYMBOLLASTCHG%CHG
ATNX
Athenex Inc
0.433+0.0236+5.76%
FBIO
Fortress Biotech Inc
0.80-0.0399-4.7506%
SELB
Selecta Biosciences Inc
1.33+0.02+1.53%
HBIO
Harvard Bioscience Inc
3.70+0.10+2.78%
CTMX
CytomX Therapeutics Inc
1.84+0.01+0.55%